Skin care brands with a “dermatitis” tag are more likely to be made in China, according to a study published in Dermatology.
The findings suggest that cosmetics brands with dermal inflammation could be less likely to benefit consumers from a dermatological perspective.
The study looked at products made by a wide variety of skin care brands from brands such as Burt’s Bees and Neutrogena.
It found that the most popular products that were labeled “dermalitis” were made in countries with high levels of inflammatory dermatitis, which can lead to serious skin conditions, such as eczema.
The researchers found that brands with “dermitis” tags were more likely than other brands to have products with less-than-optimal ingredients and to contain fewer anti-inflammatory ingredients.
“A large percentage of our samples were derived from China and other Asian countries,” said co-author Dr. David A. Shanks, professor of dermatology at the University of Pennsylvania.
“In China, there are many brands with skin care formulations that do not contain the anti-irritant ingredients and are also marketed as being skin care products for people with acne.”
Shanks and his colleagues analyzed the ingredients in nearly 800 products sold in China from 2007 to 2011.
The results were consistent across the brands they examined, with the most inflammatory brands consistently outperforming the less-inflammatory brands in terms of ingredient quality and skin care benefits.
“What we’re seeing in the U.S. is that some of the most well-known brands are being replaced by a bunch of companies that are making products that are actually more dermatologically reactive,” Shanks said.
Shops that made more inflammatory products were more expensive, which increased demand for products that weren’t necessarily dermatologically effective.
Shaysons study also revealed that more expensive brands were also more likely with more adverse skin reactions, such, burning, itching, and skin irritation.
In addition, the more expensive a brand was, the less likely it was to be a positive source of skin health benefits.
The authors also found that skin care brand brands with the “derma” tag were more common in Europe and North America, where the dermatological conditions are more severe.
The research is the latest in a long line of studies linking the cosmetics industry to inflammatory skin conditions.
The cosmetics industry has a long history of using ingredients that may increase the risk of skin cancer, but it has not been clear how products can be avoided from being used by people with inflammatory conditions.
Shakess, who is also a dermatologist, said it is important to keep in mind that the ingredients are designed to act as a mask, not as an anti-aging treatment.
“There is no safe level of the ingredient and that means it has to be very carefully monitored, so it’s not just about the ingredient but how well it is applied,” he said.
“It’s really about what you are applying it to your skin.”
A lot of dermatologists, including Shankss, have also said that there is no conclusive evidence that products with a dermatitis tag increase the likelihood of skin problems.
However, he said, there may be some evidence that the products can trigger certain skin reactions.
Shanskys study also suggests that cosmetics makers should consider how to reduce the risk that consumers are being misled.
The most inflammatory products, including those that were made with the inflammatory ingredient, were more often sold at drugstores, but that may be because drugstores were less likely than larger stores to carry the brand, he added.
Shansons study did not look at ingredients or other products that would likely be used by consumers with inflammatory dermatoses.
“If you have a condition where you have inflammatory acne, that might not be the best thing to be using,” Shansky said.